drugset / Trial / NCT00926263
A Pharmacokinetic And QT Study Of CP-751,871 In Healthy Subjects
Non-randomizedParallel-groupOpen-labelBasic science
Summary
This study is primarily to evaluate the single dose pharmacokinetics of CP-751,871 and its effect on QT interval prolongation.
Timeline
- Start
- 2009-07
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Figitumumab | Monoclonal antibody | 10 mg/kg | Intravenous |
| Subject | Figitumumab | Monoclonal antibody | 20 mg/kg | Intravenous |
| Background | Moxifloxacin | Small molecule | — | — |
Indications
No indication recorded.